Integral Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Integral Investment Advisors's PFE Position: Q2 2026 in Review
Integral Investment Advisors increased its Pfizer (PFE) stake by 7.5% in Q2 2026, buying an estimated $19K and bringing the position to 10,438 shares worth $251K. The position accounts for 0.06% of the portfolio, ranked #159.
Integral Investment Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.54M in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Integral Investment Advisors held 10,438 shares of Pfizer worth $251K as of Q2 2026.
- Integral Investment Advisors bought 725 Pfizer shares in Q2 2026, an estimated $19K.
- Pfizer made up 0.06% of Integral Investment Advisors's portfolio in Q2 2026, its #159 holding.
- Integral Investment Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Integral Investment Advisors's Pfizer position peaked at $1.54M in Q3 2024.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Integral Investment Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.